Stay updated with breaking news from Bio Techne. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Epoch Investment Partners Inc. lessened its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 4.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 31,704 shares of the biotechnology company’s stock after selling 1,591 shares during the quarter. Epoch Investment Partners Inc.’s […]
Key Insights Bio-Techne's estimated fair value is US$57.87 based on 2 Stage Free Cash Flow to Equity With US$63.58...
/PRNewswire/ -- The Market Study of Antibody Discovery Market by Phage Display from 2024 to...
US Bancorp DE lessened its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 3.0% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 157,077 shares of the biotechnology company’s stock after selling 4,813 shares during the period. US Bancorp DE’s holdings […]
StockNews.com cut shares of Bio-Techne (NASDAQ:TECH – Free Report) from a buy rating to a hold rating in a research note published on Saturday morning. Other research analysts have also recently issued reports about the company. Royal Bank of Canada lowered their target price on Bio-Techne from $85.00 to $83.00 and set a sector perform […]